U.S. Public Health Service Commissioned Corps Helps Provide Treatment To U.S. Patients Infected With COVID-19 In Japan

HHS: U.S. Public Health Service Strike Team Helps Treat Patients Infected with COVID-19 in Japan
“A team of specialized officers from the U.S. Public Health Service (USPHS) Commissioned Corps are working with the United States Embassy in Japan, the Japanese Ministry of Health, Labour and Welfare, and Gilead Sciences Inc. to provide compassionate access use of an investigational antiviral treatment for severely ill patients in Japan who have COVID-19, the disease caused by the novel coronavirus. … This specialized team of Commissioned Corps officers, with clinical, scientific, international, and public health backgrounds, deployed on February 15 to Japan to assist in the management of hospitalized United States citizens with SARS-CoV-2, the virus that causes COVID-19. Their mission is to identify seriously and critically ill patients for enrollment in a compassionate use trial so that patients with viral pneumonia could receive treatment with remdesivir, an investigational antiviral treatment developed by Gilead Sciences Inc…” (3/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.